Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 580,415 | 1,211,975 | 1,527,042 | 1,410,626 | 143,370 |
| Cost of Goods | 60,987 | 130,277 | 279,885 | 80,505 | 12,730 |
| Gross Profit | 519,428 | 1,081,698 | 1,247,157 | 1,330,121 | 130,640 |
| Operating Expenses | 1,212,827 | 1,691,983 | 1,201,315 | 1,216,806 | 827,447 |
| Operating Income | -692,412 | -610,008 | 46,727 | 113,820 | -696,077 |
| Interest Expense | 72,863 | 22,926 | 15,040 | 37,681 | 19,275 |
| Other Income | 30,400 | 6,890 | 309 | -15,694 | -39,274 |
| Pre-tax Income | -734,875 | -626,044 | 31,996 | 60,445 | -754,626 |
| Income Tax | 6,958 | -122,422 | -275 | 19,266 | N/A |
| Net Income Continuous | -741,833 | -503,622 | 32,271 | 41,179 | -754,626 |
| Net Income Discontinuous | -912 | -183,928 | -83,406 | N/A | N/A |
| Minority Interests | -4,190 | -242,522 | 55,897 | 11,605 | N/A |
| Net Income | $-738,555 | $-445,028 | $-107,032 | $29,574 | $-754,626 |
| EPS Basic Total Ops | -3.14 | -1.98 | -0.50 | 0.14 | -3.77 |
| EPS Basic Continuous Ops | -3.14 | -2.24 | 0.15 | 0.20 | -3.77 |
| EPS Basic Discontinuous Ops | 0.00 | 0.26 | -0.65 | N/A | N/A |
| EPS Diluted Total Ops | -3.14 | -1.98 | -0.50 | 0.14 | -3.77 |
| EPS Diluted Continuous Ops | -3.14 | -2.24 | 0.15 | 0.20 | -3.77 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.26 | -0.65 | N/A | N/A |
| EBITDA(a) | $-629,155 | $-561,643 | $84,918 | $148,861 | $-665,618 |